Source: http://complement.us/abstracts.asp
Timestamp: 2019-04-25 10:06:29+00:00

Document:
Janssen, B. J. C., Christodoulidou, A.Katragadda, M. Lambris, J. D. Gros, P. (2007). Structure of complement component C3b. Molecular Immunology 44(1-3):189.
Janssen, B. J. C., Halff, E., Lambris, J. D. Gros, P. (2007). Structure of C3c in complex with compstatin reveals a new mechanism of complement inhibition. Molecular Immunology 44(16):3930.
Katragadda, M., Sfyroera, G., Paola, M.Janssen, B. J. C. Gros, P.and Lambris, J. D. (2007). Structure-activity-based design of potent compstatin analogs. Molecular Immunology 44(1-3):192.
Lambris, J. D., Sfyoera, G., Hammel, M.Ricklin, D. Magotti, P. Geisbrecht, B. V. (2007). A novel complement evasion mechanism of Staphylococcus aureus using Efb. Molecular Immunology 44(16):3926.
Lambris, J. D., Sfyroera, G., Schuster, M. Chen, H.Tzekou, A.Papp, K.Winters, M. Woods, V. L. (2007). Studies on the solvent accessibility of native C3 and its fragments, as analyzed by HDX-MS. Molecular Immunology 44(1-3):202.
Markiewski, M. M., DeAngelis, R. A.Foukas, P. G. Lambris, J. D. (2007). Complement - A regulator of pro-survival pathways in liver regeneration. Molecular Immunology 44(1-3): 213-214.
Ritis, K. Doumas, M.Mastellos, D. Micheli, A. Giaglis, S. Magotti, P. Farail, S.Kartalis, G. Sideras, P. Lambris, J. D. (2007). A novel C5aR-tissue factor crosstalk in neutrophils links innate immunity to coagulation pathways. Molecular Immunology 44(1-3):266.
Sarma, V. Huber-Lang, M. Zetoune, F. S. Rittirsch, D. Lambris, J. D. Drouin, S. M. Wetsel, R. A. Ward, P. A. (2007). Generation of C5a in the absence of C3: A new complement activation pathway. Molecular Immunology 44(1-3):235.
Sfyroera, G. Melillo, D. De Santis, R. Graziano, R. Marino, R.Lambris, J. D. Pinto, M. R. (2007). First identification of a chemotactic receptor in an invertebrate species: Structural and functional characterization of Ciona intestinalis C3a receptor. Molecular Immunology 44(1-3): 238-239.
Thurman,J.M., Lenderink,A.M., Royer,P.A., Zhou,J., Lambris,J.D., Nemenoff,R.A., Quigg,R.J. and Holers,V.M. (2007). Activation of the alternative pathway of complement after renal ischemia/reperfusion induces the production of C-X-C chemokines. Molecular Immunology 44 (1-3):250.
Tjernberg, J., Lindblom, S., Ekdahl, K. N. Lambris, J. Korsgren, O. Nilsson, B. (2007). Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Xenotransplantation 14(5):454.
Waage, C. Nielsen, E. W. Fure, H.Brekke, O. L. Sfyoera, G. Lambris, J. D. Mollnes, T. E. (2007). Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Molecular Immunology 44(1-3):254.
Zhang, X. H. Kimura, Y., Fang, C. Y. Zhou, L.Sfyroera, G. Lambris, J. D. Wetsel, R. A. Miwa, T.and Song, W. C. (2007). Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Molecular Immunology 44 (1-3):263.
Archontis, G., Tarnamis, P., Skourtis, S. S. Morikis, D. Lambris, J. D. (2007). Conformational analysis of compstatin analogues with molecular dynamics simulations in explicit water. Molecular Immunology 44(1-3):150.
Engberg, A. E., Lambris, J. D., Nilsson, B. Nilsson-Ekdahl, K. (2006). Mass Spectrometric indentification of proteins that binding to biomaterial surfaces. Evidence for covalent binding of C3 to surfcae bound proteins. 4rth, International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:85.
Hamad, A. Lambris, J. D. Nilsson-Ekdahl, K. Nilsson, B. (2006). Complement activation induced by thrombin receptor-activated platelets. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:87.
Lambris, J. D. (2006). Protein-protein interactions in the complement system and development of compement therapeutics. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:60.
Markiewski, M. M., DeAngelis, R. A.Foukas, P. G. Lambris, J. D. (2006). Complement - a regulator of pro-survival pathways in liver regeneration. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:37.
Melillo, D. Sfyoera, G., De Santis, R. Graziano, R. Marino, R.Lambris, J. D. Pinto, M. R. (2006). First indentification of a chemotactic receptor in an invertebrate species: structural and functional characterization of Ciona intestinalis C3a receptor. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:41.
Stevens, B. Christopherson, K. S. Huberman, A. D. Lambris, J. D. Barres, B. A. (2006). The complement cascade mediates developmental synapse elimination. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:38.
Thurman, J. M., Lenderink, A. M.Royer, P. A. Zhou, J.Lambris, J. D. Nemenoff, R. A. Quigg, R. J. Holers, M. (2006). Activation of the alternative pathway of complement after renal ischemia/reperfusion induces the production of C-X-C chemokines. XXI ICW.Beijing, China, Molucular Immunology 44(1-3):250.
Zetoune, F. S., Huberman, A. D.Sarma, V.Rittirsch, D. Lambris, J. D. Ward, P. (2006). C5a gemeration in the absence of C3. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:43.
Zetoune,F.S., Sarma,J.V., Rittirsch,D., Lambris,J.D., McGuire,S.R. and Ward,P.A. (2006). Thrombin as a C5 convertase. Faseb Journal 20(4):A641.
Bergseth,G., Lappegard,K.T., Lambris,J.D., Fure,H. and Mollnes,T.E. (2006). Complement-dependent chemokine synthesis induced by an artificial surface: role of leukocyte subpopulations. Molecular Immunology 43(1-2):171-172.
Lambris, J. D. (2006). A "multidisciplinary" approach to understand disease pathogenesis and develp therapeutics. 4rth International Conference on Pathways, Networks and Systems: Theory and Experiments, Mykonos, Greece, Aegean Conferences 27:44.
Kohl, J. Balder, R.Lewkowich, I. Pandey, M. K Hawlisch, H. Wang, L.Herman, N.Sproles, A. Best, J.Zwirner, J. Whitsett, J. D. Lambris, J. D. Wills-Karp, M. (2005). A regulatory role for the C5a anaphylatoxin on type 2 immunity in asthma. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:35.
Lambris, J. D. (2005). Intergrating innate immunity into a "systems context"; the complement paradigm. Crossroads between innate and Adaptive Immunity. Rhodes, Greece, Aegean Conferences 21:30.
Lambris, J. D. (2005). Intergrating innate immunity into a "systems context"; the complement paradigm. 3rd International Conference on Pathways, Networks and Systems: Theory and Experiments. Rhodes, Greece, Aegean Conferences2 0:28.
Lambris, J. D. (2005). From atoms to systems: A "multidisciplinary approach to today's challenges in biosciences. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:34.
Lambris, J. D. (2005). A "multidisciplinary" approach to today's challenges in biosciences. 2nd International Conference on Tissue Enginnering, Crete, Greece, Aegean Conferences 16:88.
Lambris, J. D. (2005). A "multidisciplinary" approach to today's challenges in biosciences. 3rd Workshop on Lymphocyte Signal Transduction, Crete, Greece, Aegean Conferences 17:63.
Madhavan, M. C., Tsonis, P. A., Lambris, J. D. Del Rio-Tsonis, K. (2005). A role of complement components in regeneration. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:24.
Mocco, J. Mack, W. J. Botto, M.Holland, M. C. H. Lambris, J. D. Pinsky, D. J. Connolly, E. S. (2005). Aggressive reduction of C3 is critical to alleviating complement mediated injury following cerebral ischemia/reperfusion. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:29.
Reca, R. Lambris, J. D., Ross, G. D. Ratajczak, M. (2005). Transplantation studies in C3-deficient animals reveal a novel role of third complement component(C3) in engrament/regeneration of bone marrow. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:25.
Fabry, Z. Nacewicz, B. Liu, F.Sewell, D.Macvilay, S. Erdei, A.Lambris, J. D. Sandor, M. (2004). Role of complement in acute traumatic brain injury. Molecular Immunology 41(2-3):227.
Lambris, J. D. (2004). From Atoms to Systems: A "Multidisciplinary" Approach to Innate Immunity. 3rd International Conference on Innate Immunity, Mykonos, Greece, Aegean Conferences 13:63.
Lambris, J. D., Katragadda, M., Spruce, L.and Morikis, D. (2004). The compstatin case: an UPDATE, on its structure and functions. Molecular Immunology 41(2-3):265.
Mallik,B., Lambris,J.D. and Morikis,D. (2004). Rational design of a potent inhibitor for unregulated complement activation using molecular dynamics simulations and nuclear magnetic resonance data. Abstracts of Papers of the American Chemical Society 227:U908-U909.
Markiewski, M. M., Mastellos, D., Tudoran, R. Strey, C. W. DeAngelis, R. A. Franchini, S. Wetsel, R. A. Erdei, A.and Lambris, J. D. (2004). The role of complement in liver regeneration: both C3a and are critical for normal liver recovery after toxic injury. Molecular Immunology 41(2-3):273.
Morikis, D. Mallik, B.and Lambris, J. D. (2004). NMR and molecular simulations as tools for characterization of compastatin and active hybrid peptide-peptidomimetic analogs. Molecular Immunology 41:281-282.
Morikis,D. and Lambris,J.D. (2004). Electrostatics drive C3D-CR2 association. Abstracts of Papers of the American Chemical Society 227:U913.
Sandor, M. Lambris, J. D. Suresh, M. (2004). Complement Regulates T Cell Responses. 3rd International Conference on Innate Immunity, Mykonos, Greece, Aegean Conferences 13:37.
Sfyroera, G. Isaacs, S. N. Katragadda, M. Lambris, J. D. (2004). Structural-functional analysis of VCP and SPICE interactions with C3b. Molecular Immunology 41(2-3): 305-306.
Winters,M.S., Spellman,D.S. and Lambris,J.D. (2004). Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/deuterium exchange and mass spectrometry. Protein Science 13 :102-103.
Yamada, K. Miwa, T.Liu, J.Nangaku, M. Lambris, J. D. Song, W. C. (2004). Critical protection from renal ischemia reperfusion injury by DAF and CD59. Molecular Immunology 41(2-3): 328-329.
Allendorf, D. J., Baran, J. T., Hansen, R. D. Subbarao, K. Walsh, D.Hong, F.Marroquin, J. Yan, J.Lambris, J. D. Haribabu, B. Ross, G. D. (2003). Orally administered beta-glucan functions via anti-tumor mAbs and the complement system to recruit CR3(+) neutrophils and macrophages that produce tumor regression and tumor-free survival. Molecular Immunology 40(2-4): 195-196.
Blatteis, C. M., Li, S. X., ballou, L. R. Boackle, S. A. Holers, M.and Lambris, J. D. (2003). Complement and the pathogenesis of endotoxic fever. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:59.
Girardi, G. Berman, J.Hollmann, T. Lambris, J. D. Wetsel, R. A. Holers, M.and Salmon, J. E. (2003). C5a-C5aR interactions and recruitment of PMN mediate antiphospholipid antibody(aPL)-induced pregnancy loss in mice. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:54.
Girardi, G. Berman, J.Tudoran, R. Chinnici, C. Erdei, A.Lambris, J. Salmon, J. (2003). A potential mechanism for therapeutic efficacy for heparin in antiphospholipid-induced pregnancyloss-inhibition of complement. Arthritis and Rheumatism 48(9):S163.
Lambris, J. D., Del Rio-Tsonis, K.Franchini, S. Kimura, Y.Markiewski, M. M. Mastellos, D. Strey, C. W. Tsonis, P. A. (2003). The role of complement in developmental processes. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:52.
Li, S. X. Lambris, J. D. Blatteis, C. M. (2003). Complement(C) and lipopolysaccharide(LPS)-induced fever: C5a is essential. Faseb Journal 17(7):C108.
Li, S. X. Lambris, J. D. Blatteis, C. M. (2003). Complement(C) and lipopolysaccharide(LPS)-induced fever: C5a is essential.. Faseb Journal 17(7):C108.
Madhavan, M. C., Kimura, Y., Call, M. K. Santiago, W. Tsonis, P. A. Lambris, J. D. Del Rio-Tsonis, K. (2003). Do complement molecules play a role in lens regeneration?. Investigative Ophthalmology & Visual Science 44:U324.
Morikis, D. Mallik, B.and Lambris, J. D. (2003). Molecular dynamics simulations of the NMR structural ensemble of Compstatin: A first step towards dynamics-activity relations in rational drug design. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:45.
Morikis, D.and Lambris, J. D. (2003). Immunophysics of the complement system: The role of electrostatic fields in C3d-CR2(SCR1/SCR2) association. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:44.
Mullick, J. Bernet, J.Singh, A. K. Lambris, J. D. Sahu, A. (2003). Kaposi's sarcoma-associated herpesvirus open reading frame 4 protein(Kaposica) targets C3 and C4 to inactivate complement. Molecular Immunology 40(2-4):175.
Ross, G. D. Hansen, R. D. Allendorf, D. J. Baran, J. T. Yan, J.Subbarao, K. Haribabu, B. Lambris, J. D. (2003). Tumor regression mediated by beta-glucans against iC3b-opsonized tumors requires CR3(+) neutrophils recruited via C5a and leukotriene B-4(LTB4). Faseb Journal 17(7):C128.
Yamada, K. Miwa, T.Liu, J. N.Funk, C.Lambris, J. D. Nangaku, M. Song, W. C. (2003). Time-dependent involvement of complement and leukotriene pathways in a mouse model of renal ischemia reperfusion injury. Journal of the American Society of Nephrology 14:565A.
Brekke, O. L., Fure, H. Christiansen, D.Lappegard, K. T. Fung, M.Lambris, J. D. Mollnes, T. E. (2002). Key role of the C5a receptor in Escherichia coli-induced oxidative burst and phagocytosis studied in a novel human whole blood model of inflammation. International Immunopharmacology 2:1235.
Erdei, A. Laszlo, G.POlah, E.Prechi, J.Papp, K.Csomor, E.Argyropoulos, E. Franchini, S. Mastellos, D. Lambris, J. D. (2002). Monoclonal antibodies against mouse C3-fragments; A new repertoire of reagents targeting C3-mediated functions. International Immunopharmacology 2:1327.
Fleming, S. D., Lambris, J. D., Shea-Donohue, T. Tsokos, G. C. (2002). The C5a fragment of C5 is critical for the mesenteric ischemia/reperfusion-induced local and remote organ injury. Int.Immunopharmacol 2(9):1308.
Girardi, G. Berman, J.Spruce, L.Lambris, J. D. Holers, M.and Salmon, J. E. (2002). A critical role for complement C5 in antiphospholipid antibody-induced pregnancy loss. Arthritis and Rheumatism 46(9):S219.
Girardi, G. Berman, J.Spruce, L.Lambris, J. D. Holers, M.and Salmon, J. E. (2002). Complement C5 activation mediates antiphospholipid antibody-induced pregnancy loss. Int.Immunopharmacol 1239.
Kijowski, J. Reca, R.Majka, M.Mastellos, D. Janowska-Wieczorek, A. Lambris, J. Ratajczak, M. Z. (2002). Evidence that anaphylatoxin C3a cooperates with SDF-1 in homing/mobilization of hematopoietic stem/progenitors by priming CXCR4 responses to SDF-1. Blood 100(11):108A.
Kimura, Y. Lambris, J. D. Tsonis, P. A. Del Rio-Tsonis, K. (2002). The role of compelement in newt lens and limb regeneration. International Immunopharmacology 2:1364.
Lappegard, K. T., Hvassing, T., Fung, M.Lambris, J. D. Riesenfeld, J. Mollnes, T. E. (2002). Attenuation of artificial surface-induced leukocyte activation by blocking C2, factor D, C5 and C5a receptor. International Immunopharmacology 2:1308.
Miwa, T. Zhou, L.Hilliard, B. Lambris, J. D. Molina, H.and Song, W. C. (2002). Differential roles of DAF, Crry and CD59 in regulating alternative and classical pathway complement activation on murine erythrocytes. International Immunopharmacology 2:1223.
Morikis, D. Soulika, A. M Lambris, J. D. (2002). Rational design of a complement inhibitor targeting C3 using NMR and combinatorial approaches. Biochemical Society Transactions 30:A100.
Morikis, D. Soulika, A. M Lambris, J. D. (2002). Structural-activity based design of compstatin using analogs NMR and combinatorial approaches. International Immunopharmacology 2:1229-1230.
Nacewicz, B. Liu, F.Sewell, D.Lambris, J. D. Sandor, M.and Fabry, Z. (2002). The role of complement in traumatic injury of the brain. Faseb Journal 16(4):A682.
Ratajczak, M. Z., Reca, R.Majka, M., Kijowski, J. Mastellos, D. (2002). The role of a newly identified heterologous crosstalk between G-protein coupled seven-transmembrane span receptors: Chemokine receptor CXCR4 and complement C3aR in human hemato-lymphopoiesis and innate immunity. International Immunopharmacology 2: 1351.
Reca, R. Majka, M.Janowska-Wieczorek, A. Lambris, J. Ratajczak, M. (2002). A new unexpected role of the third complement component (C3a)-C3a receptor(C3aR) axis in regulating human hematopoiesis. Experimental Hematology 30(6):59.
Reca, R. Majka, M.Mastellos, D. Janowska-Wieczorek, A. Lambris, J. D. Ratajczak, M. Z. (2002). Normal human CD34 hematopoietic progenitors, myeloblasts, megakaryoblasts and erythroblasts express functional complement C3a receptor that sensitizes their chemotactic responses to SDF-1. Blood 100(11):148B.
Spruce, L. Argyropoulos, E. Mastellos, D. Sfyoera, G. Lambris, J. D. (2002). Chemical synthesis of small complement proteins and protein modules. International Immunopharmacology 2:1320-1321.
Strey, C. W. Markiewski, M. M. Mastellos, D. Tudoran, R. Greenbaum, L. Lambris, J. (2002). The role of complement in liver regeneration. International Immunopharmacology 2:1249.
Strey, C. W. Spellman, d Markiewski, M. M. Lambris, J. D. (2002). Proteomic analysis of mouse C3 deficiency and liver partial hepatectomy. International Immunopharmacology 2:1241.
Wyss-Coray, T., Lin, A. H. T., Yan, F. R.Lambris, J. Alexander, J. J. Quigg, R. J. Masliah, E. (2002). Overproduction of complement inhibitor Crry increases Alzheimer's-type pathology in transgenic mice. Neurobiology of Aging 23: S221.
Zetoune, F. S., Huber-Lang, M. S.Riedemann, N. C. Sarma, V.Neff, T.Younkin, E. M. Laudes, I. J. McGuire, S. R. Guo, R. F.Lambris, J. D. Spruce, L.Mastellos, D. Ward, P. A. (2002 ). Role for C5a in mouse peritoneal sepsis. Faseb Journal16 (4):A592.
Christiansen, D., Fure, H.Bergseth, G., Lambris, J. D. Mollnes, T. E. (2001). E-coli-induced upregulation of granulocyte CR3 contributes to oxidative burst and is totally C5a receptor dependent. Molecular Immunology 38(2-3):83.
Fure, H. Christiansen, D. Brekke, O. L. Bergseth, G. Lappegard, K. T. Lambris, J. D. Fung, M.and Mollnes, T. E. (2001). E-coli-induced oxidative burst is complement dependent and can be abolished by different modes of complement inhibition. Molecular Immunology 38(2-3): 90-91.
Kijowski, J. Majka, M.Reca, R.Rozmyslowicz, T. Conover, D. O. Murphy, S. L. Janowska-Wieczorek, A. Gaulton, G. N. Lambris, J. Ratajczak, M. Z. (2001). The role of newly-identified heterologous crosstalk between G-protein coupled chemokine and complement seven transmembrane span receptors in human thymopoiesis. Blood 98(11):821A.
Lappegard, K. T., Bergseth, G., Lambris, J. D. Riesenfeld, J. Mollnes, T. E. (2001). Studies on the relationship between complement and leukocyte activation in blood circulated in uncoated and heparin coated PVC tubing. Molecular Immunology 38(2-3):105.
Reca, R. Majka, M.Mastellos, D. Zhao, D. L. Janowska-Wieczorek, A. Lambris, J. D. Ratajczak, M. Z. (2001). New unexpected stimulatory effects of complement proteins on human hematopoiesis: Evidence for crosstalk between G-protein-coupled C3a complement receptor(C3aR) and alpha-chemokine SDF-1 receptor(CXCR4). Blood 98(11):64A.
Solvik, U. O., Haraldsen, G., Fiane, A. E. Boretti, E. Lambris, J. D. Fung, M.Thorsby, E. Mollnes, T. E. (2001). Human serum-induced E-selectin expression on porcine aortic endothelial cells is totally complement mediated: evidence for a role of complement in delayed xenograft rejection. Xenotransplantation 8:120.
Franchini, S., Zarkadis, I. K.Sfyroera, G. Sahu, A.and Lambris, J. D. (2000). Cloning and purification of the rainbow trout fifth component of complement(C5). Immunopharmacology 49:13.
Friedman, H. M., Saldanha, C., Wang, L. Y. Jiang, M.Grippi, K.Lambris, J. D. Lubinski, J. (2000). Herpes simplex virus immune evasio. Clinical Infectious Diseases 31(1):316.
Guthridge, J., Rakstang, J, Young, KHinshelwood, J. Sarrias, M. R. Moore, W. T. Perkins, S. J. Overduin, M. Lambris, J. D. Karp, D.Hannan, J.and Holers, M. (2000). CR2/CD21 SCR1,2 domain ligand binding, physical properties and structural analysis. Immunopharmacology 49: 46.
Guthridge, J., Younf, K. , Gipson, M.Hinshelwood, J. Sarrias, M. R. Lambris, J. D. Perkins, S. J. Holers, M. (2000). Novel inhibitory monoclonal antibodies to human CR2/CD21 ligand binding domains. Immunopharmacology 49:69.
Lambris, J. D., Zarkadis, I. K.Sarrias, M. R. Franchini, S. Sfyroera, G. Sahu, A. (2000). Structure and fuctions of trout complement proteins. Dev.Comp. Immunology 24:23.
Mastellos, D., papadimitriou, SFranchini, S. Tsonis, P. A. Lambris, J. D. (2000). A role of Complement component C5 in liver regeneration. Immunopharmacology 49:8.
Mollnes, T. E., Brekke, O. L., Koehl, J.Bergseth, G. Christiansen, D. Fure, H.Lappegard, K. T. Videm, V.Sahu, A.and Lambris, J. D. (2000). Inhibition of endotoxin-induced oxidative burst by the C3 binding peptide compstatin in a novel whole blood model of inflammation. Immunopharmacology 49:62.
Moore, W. T.and Lambris, J. D. (2000). Proteomic analysis of C3 and its fragments. Immunopharmacology 49:43.
Sahu, A. Soulika, A. M Morikis, D. Spruce, L.Moore, W. T. Lambris, J. D. (2000). Kinetics and proposed mechanism of binding of the complement inhibitor Compstatin. Immunopharmacology 49:53.
Song, W. C. Scalia, R.Miwa, T.Lambris, J. D. Lefer, A. M. (2000). Dificiency of decayaccelerating factor(DAF) attenuates leukocyte-endothelium interation induced by hemorrhage and reinfusion. Immunopharmacology 49:24.
Soulika, A. M, Khan, T.Hattori, F. W, Bowen, B. A Richardson, C. E Hack, C. E. Sahu, A.Edmunds, L. H Lambris, J. D. (2000). Inhibition of heparin/protamine complex-induced complement activation by Compastatin in baboons. Immunopharmacology 49:62.
Zarkadis, I. K., Sfyroera, G., Franchini, S. Sahu, A.and Lambris, J. D. (2000). Characterization of factor H-like molecules in rainbow trout. Dev.Comp.Immunol 24:13.
Irani, V. R.and Lambris, J. D. (1999). Studies on the interaction of C3dg with CR2. Faseb Journal13 (4):A282.
Lambris,J.D. and Volanakis,J.E. (1999). Special Issue - Papers presented at the XVIIth International Complement Workshop - Rhodes, Greece - 11-16 October 1998 - Preface. Immunopharmacology 42 (1-3):IX.
Noorchashm, H., Moore, D. J., Lieu, Y. K., Noorchashm, N., Schlachterman, A., Song, H. K., Lambris, J. D., Barker, C. F., and Naji, A. (1999). Contribution of the innate immune system to autoimmune diabetes: A role for the CR1/CR2 complement receptors. Cellular Immunology 198(2):143.
Friedman,H.M., Wang,L., Nagashunmugam,T., Lambris,J.D., Pangburn,M.K., Sahu,A., Soulika,A., Wetsel,R.A., Colten,H., Eisenberg,R.J., Cohen,G.H. and Lubinski,J. (1998). HSV-1 glycoprotein gC complement regulatory domains involved in virulence. Molecular Immunology 35 (6-7):348.
Lambris,J.D. and Volanakis,J.E. (1998). Abstracts of the XVII international complement workshop - Preface. Molecular Immunology 35 (6-7):329.
Mollnes,T.E., Fiane,A.E., Videm,V., Sahu,A., Hovig,T., Mellbye,O.J., Hogasen,J., Spruce,L., Moore,W. and Lambris,J.D. (1998). Attenuation of hyperacute xenograft rejection in a porcine-to-human ex vivo model by a peptide based C3 inhibitor. Molecular Immunology 35(6-7):372.
Moore,W.T. and Lambris,J.D. (1998). Mass spectrometric analysis of the activation and expression products of the third component of complement (C3). Molecular Immunology 35(6-7):373.
Mvones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D.(1998). Cofactor activity for C3 cleavage is preserved in complexes of complement factor H and phospholipids: Relationship to antiphospholipid antibodies. Arthritis and Rheumatism, 41(9):S172Mvones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D. (1998). Cofactor activity for C3 cleavage is preserved in complexes of complement factor H and phospholipids: Relationship to antiphospholipid antibodies. Arthritis and Rheumatism 41(9):S172.
Myones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D. (1998). Complexes of factor H and phospholipids retain cofactor activity for C3 cleavage: Relationship to antiphospholipid antibodies. Molecular Immunology 35 (6-7):373.
Nilsson, B., Larsson, R., Hong, J., Elgue, G., Ekdahl, K. N., Sahu, A., and Lambris, J. D. (1998). Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Molecular Immunology 35(6-7):371.
Noorchashm,H., Lieu,Y.K., Wetsel,R., Colten,H.R., Barker,C.F., Soulika,A., Rostami,S.Y., Lambris,J.D. and Naji,A. (1998). B cell tolerance: A C3 dependent process. Molecular Immunology 35(6-7):371.
Sahu, A., Isaacs, S. N., Soulika, A. M., and Lambris, J. D. (1998). Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-MEDIATED degradation of C3b to IC3b(1) inactivates the alternative complement pathway. Molecular Immunology 35 (6-7):371.
Sahu,A., Morikis,D., Soulika,A.M., Spruce,L., Moore,W.T. and Lambris,J.D. (1998). Species specificity, structural functional analysis and biotransformation studies on Compstatin, a potent complement inhibitor. Molecular Immunology 35 (6-7):371.
Sarrias,M.R., Zarkadis,I., Sunyer,J.O. and Lambris,J.D. (1998). Cloning of three trout C3 isoforms: Structural, functional, and phylogenetic analysis. Molecular Immunology 35(6-7):370.
Solvik,U.O., Mollnes,T.E., Fiane,A.E., Vartdal,F., Endresen,M., Thorsby,E. and Lambris,J.D. (1998). Inhibition of complement and xenogeneic endothelial cell activation by Compstatin. Molecular Immunology 35(6-7):372.
Soulika,A.M., Sahu,A. and Lambris,J.D. (1998). Localization of Compstatin binding site on C3. Molecular Immunology 35(6-7):370.
Sun,X., Funk,C.D., Deng,C., Sahu,A., Lambris,J.D. and Song,W.C. (1998). Targeted disruption of the murine decay-accelerating factor(DAF) gene: Studies of erythrocytes reveal activity of DAF in regulating both autologous and heterologous complement activation. Molecular Immunology 35 (6-7):372.
Sunyer,J.O. and Lambris,J.D. (1998). Evolution and diversity of the complement system of poikilothermic vertebrates. Immunological Reviews 166:39-57.
Sunyer,J.O., Zarkadis,I., Sarrias,M.R., Hansen,J.D., Skiadas,A.P. and Lambris,J.D. (1998). Cloning, structure, and function of two rainbow trout Bf molecules: Both classical and alternative pathway activities require the presence of Bf-2. Molecular Immunology 35(6-7):370.
Del Rio-Tsonis, K., Tsonis, P. A., Zarkadis, I. K. Tsangas, A. G. Lambris, J. D. (1997). Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles. Molecular Immunology 34:372.
Friedman, H. M., Wang, L.Nagashunmugam, T.Lambris, J. D. Pangburn, M. K. Soulika, A. M Wetsel, R. A. Colten, H. R Eisenberg, R. J., Cohen, G. H. Lubinski, J. (1997). JSL-1 glycoprotein gC complement regulatory domains involved in virulence. Molecular Immunology 34:348.
Gross, P. S. Sunyer, J. O. Lambris, J. D. Smith, L. C. (1997). The sea urchin complement C3 protein: Expression and function. Dev.Comp.Immunol 21(2):150.
Lambris, J. D., Zarkadis, I. K., and Sunyer, J. O. (1997). Phylogeny and diversity of the third complement component C3. 7th ISDCI Congress.Develop.Comp.Immunol 21:143.
Mollnes, T. E., Fiane, A. E., Videm, V.Sahu, A.Hovig, T.Mellbye, O. J. Hogasen, K. Spruce, L.Moore, W. T. Lambris, J. D. (1997). Atytenuation of hyperacute xenograft rejection in a porcine-to-human ex vivo model by peptide based C3 inhibitor. Molecular Immunology 34:372.
Moore, W. T.and Lambris, J. D. (1997). Mass spectrometric analysis of the activation and expression products of the third component of complement(C3). Molecular Immunology 34:373.
Myones, B. L., Antonov, I. V., Fedorova, L. I. Volgin, A. Y. Lambris, J. D. Peterson, L. H. (1997). Complexes of complement factor H and phospholipids retain cofactor activity for C3 cleavage and are capable of binding human monoclonal antiphospholipid antibodies. Arthritis and Rheumatism 40(9):431.
Myones, B. L., Antonov, I. V., Fedorova, L. I. Volgin, A. Y. Peterson, L. H. Lambris, J. D. (1997). Complexes of factor H phospholipids retain cofactor activity for C3 Cleavage: relationship to antiphospholipid antibodies. Molecular Immunology 34:373.
Nilsson, B. Larsson, R., Hong, J.Elgue, G.Nilsson-Ekdahl, K. Sahu, A.and Lambris, J. D. (1997). Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal cilculation. Molecular Immunology 34:371.
Noorchashm, H., Lieu, Y. K, Wetsel, R. A. Colten, H. R Barker, C. F Soulika, A. M Rostami, S. Y. Lambris, J. D., and Naji, A. B. (1997). B cell tolerance: a C3 depedent process. Molecular Immunology, Noorchashm, H., Lieu, Y. K, Wetsel, R. A. Colten, H. R Barker, C. F Soulika, A. M Rostami, S. Y. Lambris, J. D., and Naji, A. B. (1997). B cell tolerance: a C3 depedent process. Molecular Immunology 34:371.
Sarrias, M. R., Zarkadis, I. K.Sunyer, J. O. Lambris, J. D. (1997). Cloning of three trout C3 isoforms: structural, functional, and phylogenetic analysis. Molecular Immunology 34:370.
Solvik, U. O., Mollnes, T. E., Fiane, A. E. Vartdal, A. E. Endresen, M. Thorsby, E. Lambris, J. D. (1997). Inhibition of complement and xenogeneic endothelial cell activation by compstatin. Molecular Immunology 34:372.
Soulika, A. M, Sahu, A. and Lambris, J. D. (1997). Localization of compstatin binding site on C3. Molecular Immunology 34:370.
Sunyer, J. O., Zarkadis, I. K., and Lambris, J. D. (1997). Structural and functional characterization of B/C2 complement molecules in teleost fish. Develop.Compar.Immunol 21(2):147.
Sunyer, J. O., Zarkadis, I. K.Sarrias, M. R. Hansen, R. D. Skiadas, A. P Lambris, J. D. (1997). Clining, structure and function of two rainbow trout Bf molecules: both classical and alternative pathway activities require the presence of Bf-2. Molecular Immunology 34(370).
Tolnay, M. Lambris, J. D. Tsokos, G. C. (1997). An inducible heterogeneous nuclear ribonucleoprotein which functions as a DNA-binding transactivator. Faseb Journal 11(9):A943.
Al-Sharif, W., Sunyer, J. O., Lambris, J. D. Smith, L. C. (1997). Characterization of the cDNA encoding a protein homologous to the mammalian complement component C3 which is expressed in sea urchin coelomocytes. 7th ISDCI Congress.Develop.Comp.Immunol 21:147.
Fisk, B. Dague, B.Seifert, W. E. Lambris, J. D. Papayannopoulos, I. Kudelka, A. Wharton, J. T. Ioannides, C. G. (1996). Ovarian cytotoxic T lymphocytes can recognize common peptides presented by HLA-A2+ tumors. Joint Meeting of the American Society for Biochemistry and Molecular Biology, the American Society for Investigative Pathology andthe American Association of Immunologists, New Orleans, Louisiana, USA 10(6): 2707.
Friedman, H. M., Wang, L.Burger, R., Lambris, J. D. Eisenberg, R. J. Cohen, G. H. Lubinski, J. (1996). The role of Herpes Simplex Virus type 1 glycoprotein C, a C3b binding protein, in pathogenesis. XVI International Complement Workshop Mol.Immunol 33:63.
Friedman, H. M., Wang, L.Fishman, N. O., Lambris, J. Eisenberg, R. J. Cohen, G. H. Pangburn, M. K. Lubinski, J. (1996). Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. Journal of Investigative Medicine 44(3):A218.
Sahu, A. Isaacs, S. N. Lambris, J. D. (1996). Modulation of complement by recombinant vaccinia virus complement control protein. XVI International Complement Workshop Mol.Immunol 33:61.
Sahu, A. Kay, B. K.and Lambris, J. D. (1996). Inhibition of human complement bya C3 binding peptide isolated from a phage-displayed random peptide library. XVI International Complement Workshop Mol.Immunol 33:61.
Sunyer, J. O., Zarkadis, I. K.Sahu, A.and Lambris, J. D. (1996). Multiple forms of complement C3 in a tetraploid ad a diploid teleost fish, that differ in binding to complement activators. XVI International Complement Workshop Mol.Immunol 33:61.
Tolnay, M.and Lambris, J. D. (1996). Purification and characterization of a nuclear protein and binds to a CRE-like motif in the promoter region of the complement receptor-2(CR2) gene. Joint Meeting of the American Society for Biochemistry and Molecular Biology, The american Society for Investigatinve Pathology and the American Association of Immunologists, New Orleans, Louisiana,USA, June 2-6.FASEB Journal 10(6):A1445.
Kozlowski, L. M., Lambris, J. D., and Levinson, A. I. (1995). Activation of the Complement Cascade by A Putative B-Cell Superantigen. Journal of Allergy and Clinical Immunology 95(1):177.
Kozlowski, L. M., Lambris, J. D., and Levinson, A. I. (1995). B-Cell Superantigen-Mediated Complement Activation in Mouse and Man. Faseb Journal 9(3):A518.
Lambris, J. D., Mavroidis, M., and Sunyer, J. O. (1995). Isolation, primary structure and evolution of chicken C3 and evidence for a new member of thea2-M family. FASEB J 9(3):A490.
Tolnay, M. Lambris, J. D. Smallridge, R. C. Tsokos, G. C. (1995). Transcriptional Control of the Complement Receptor-2 Gene by and Inducible Nuclear-Protein That Binds to A Camp Regulatory Element-Like Motif in the Promoter Region of the Gene. Arthritis and Rheumatism 38(9):27.
Tolnay, M. Lambris, J. D. Tsokos, G. C. (1995). Regulation of Complement Receptor-2(Cr-2) Expression in Human B-Lymphoblastoid Cell(Blc) Lines. Faseb Journal 9(3):A212.
Tsoukas, C. D., Todd, S. C., and Lambris, J. D. (1994). Epstein-Barr-Virus Induces Proliferation of Human Thymocytes in A Mhc Class Ii-Dependent Fashion. Journal of Cellular Biochemistry 370.
Hedrick, J. A., Lao, Z.Du, J.Lambris, J. D., and Tsoukas, C. D. (1993). Characterization of a novel EBV/C3 receptor. Mol.Immunol 30:15.
Kostavasili, I., Peng, C.Hung, S. L., Wang, Y.Friedman, H. M. Eisenberg, R. Cohen, G. H. Lambris, J. D. (1993). Mapping of HSV-1 and HSV-2 gC interaction sites in C3 and modulation of C3 functions. Mol.Immunol 30:25.
Lambris, J. D., Mavroidis, M., Lao, Z.Pappas, J.Wang, Y.and Suner, O. (1993). Clonning of trout, chicken, and xenopus gilli C3: conservation of functional sites in the C3 from different species. Mol.Immunol 30:27.
Lao, Z. Wang, Y.and Lambris, J. D. (1993). Interaction of human CR1, CR2 and H with expressed C3 and chimeric C3 modules. Mol.Immunol 30:27.
Lambris, J. D., Zhege, L., Wang, Y.Manzone, H. Pang, J.Schwager, J. Mavroidis, M. Alsenz, J. (1992). Evolution of C3-Ligand Interactions. Faseb Journal 6(4):A1453.
Sinha, S. K. Speiser, C. L. Hedrick, J. A. Escobar, S. Lambris, J. D. Tsoukas, C. D. (1992). Characterization of the Ebv/C3 Receptor on Human Lymphocytes-T. Faseb Journal 6(4): A1451.
Hedrick, J. A. Watry, D.Speiser, C. O' Donneli, P. Lambris, J. D. Tsoukas, C. D. (1991). Epstein-Barr virus-T lymphocyte interaction via a novel receptor. FASEB J 5(5):A1340.
Pruksananonda, S., Caltalbiano, S.Lambris, J. D. Lyttle, C. R. (1991). Hormonal regulation of rat uterine C3 and factor B. Complement and Inflammation 8:213.
Alsenz, J. Becherer, D., Esparza, I. Daoudaki, M. Avila, D.Oppermann, S. Lambris, J. D. (1989). Structure and Function Analysis of C3 from Different Species. Complement and Inflammation 6:307.
Becherer, J. D., Alsenz, J. A., Hack, C. E. Drakopoulou, E. Lambris, J. D. (1989). Identification of common binding domains in C3b for members of the complement family of C3b-binding proteins. Complement and Inflammation 6:313.
Esparza, I. Vilbois, F., Becherer, J. D. Lambris, J. D. (1989). Multiple sites of interaction in C3 for CR2/EBV-receptor: functional implications. Complement and Inflammation 6:334.
Huemer, H. P., Burger, R., Garred, P.Cohen, G.Eisenberg, R. Friedman, H. Esparza.I.Dierich, M. P. Lambris, J. D. (1989). The interaction sites in C3b for HSV-1 gC and factor H are related. Complement and Inflammation 6:348.
Myones, B. L., Avila, D. , Lachmann, P. J. Lambris, J. D. (1989). Lacalization of the epitopes recognized by anti-C3dg(clone 9) monoclonal antibody using synthetic peptides. Complement and Inflammation 6:373.
Nilsson, B. Grossberger, D. Nilsson-Ekdahl, K. Riegert, P. Becherer, J. D. Nilsson, U. R. Lambris, J. D. (1989). Localization of neoantigenic epitopes in bound C3 fragments. Complement and Inflammation 6:181.
Nilsson-Ekdahl, K., Nilsson, B., Becherer, J. D. Nilsson, U. R. Lambris, J. D. (1989). Further studies on the degradation of complement factor C3 by factor I. Inhibition of factor I with DFP. Complement and Inflammation 6:332.
Tsokos, G. Lambris, J. D. Finkelman, F. D. Anastasiou, E. D. June, C. H. (1989). Monovalent ligants of complement receptor 2 inhibit while polyvalent ligants enhance anti-immunoglobulin induced human B cell intracytoplasmic free calcium concentration. Complement and Inflammation 6:407.
W�rner, I. Burger, R.and Lambris, J. D. (1989). Localization and functional characterization of epitopes on alpha and beta chains of C3. Complement and Inflammation 6:416.
Alsenz, J.and Lambris, J. D. (1988). Modulation of factor H(H) functional activities by monoclonal antibodies(MoAbs) to H. Complement 5:202.
Bogen, B.and Lambris, J. D. (1988). An eleven aminoacid long peptide activates idiotope-specific, I-E d restricted T cell clones. International Immunology Meeting, Berlin 15:4.
Grossberger, D., Riegert, P., Becherer, J. D. Nilsson, B. Nilssonekdahl, K. Nilsson, U. R., and Lambris, J. D. (1988). Monoclonal Anti-C3 Antibodies Specific for Either Bound Or Fluid Phase C-3 - Mapping of Their Antigenic Sites in C-3 by the Use of Expression Minilibrary. Faseb Journal 2(6):A1643.
Nilsson, B. Nilsson Ekdahl, K. Avila, D.Nilsson, U. R. Lambris, J. D. (1988). Monoclonal anti-C3 antibodies specific for bound iC3b: Mapping of the recognized epitopes on C3 by synthetic peptides. Complement 5:206.
Huemer,H.P., Broker,M., Lambris,J. and Dierich,M.P. (1988). Hsv Type-1 Interaction with Human Complement-Binding Specifity of A Viral Pathogenicity Factor. Immunobiology 178(1-2):63.
Becherer, D.and Lambris, J. D. (1987). Localization of C3b receptor binding domain in C3. Complement 4:132.
Becherer, J. D., Daoudaki, M. E., and Lambris, J. D. (1987). Conservation of the C-3 Ligand-Binding Sites Within Different Species. Federation Proceedings 46(3):771.
Daoudaki, M. E. and Lambris, J. D. (1987). The properdin binding site in C3 as delineated by synthetic peptides. Complement 4:146.
Daoudaki, M. E., Becherer, J. D., and Lambris, J. D. (1987). Localization of the P and C5 binding sites on the third component of complement. Fed.Proc 46:1024.
Lambris, J. D., Avila, D., and Becherer, J. D. (1987). Interaction of factor H with C3 :Involvement of two C3 sites in the H cofactor activity. Complement 4:183.
Lambris, J. D., Becherer, J. D.Avila, D.and M�ller-Eberhard, H. J. (1986). Localization of the factor H binding site on the third component of complement. Immunobiology 173:493.
Fishelson, Z., Lambris, J. D., and M�ller-Eberhard, H. J. (1985). Modulation of complement C3bBb activity and stability by monoclonal antibodies to Bb. Complement 2:25.
Hirani, S. Lambris, J. D. Mullereberhard, H. J. (1985). Analysis of the Carbohydrate Moieties of the 3Rd Component of Human-Complement. Federation Proceedings 44(4):989.
Lambris, J. D., Becherer, D., and M�ller-Eberhard, H. J. (1985). Localization of the factor H binding site on complement C3. Complement 2:48.
Lambris, J. D., Ganu, V. S., Hirani, S.and Mullereberhard, H. J. (1985). Mapping of the C3D Receptor(Cr2)-Binding Site and A Neoantigenic Site in the C3D Domain of the 3Rd Component of Complement. Proceedings of the National Academy of Sciences of the United States of America 82(12):4235.
Lambris, J. D., Hirani, S., Ganu, V. S. Becherer, D. M�ller-Eberhard, H. J. (1985). Localization of the complement C3d receptor binding site and monoclonal antibody 130 antigenic site on complement C3. Fed.Proc 44:1531.
Tsokos, G. C. and Lambris, J. D. (1985). Modulation of Cyto-Toxic Responses by Complement - C3C3B and C3D Fragments Enhance Allogeneic Cell-Mediated Lympholysis. Federation Proceedings 44(6):1877.
Aguado, M. T., Lambris, J. D., Tamerius, J. D. Dixon, F. J. Theofilopoulos, A. N. (1984). Use of anti-C3 monoclonal antibodies to detect C3-bearing immune complexes and complement activation. Fed.Proc 43:1614.
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P. (1984). Structure-Function Relationship of Factor-H Investigated by Enzymatic Cleavages and Monoclonal Anti-H Antibodies. Immunobiology 168(1-2):97.
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P. (1984). The C3b binding site and the cofactor activity is localized in the 38Kd trypsin fragment of factor H. Fed.Proc 43:1447.
Lambris, J. D., Hirani, S., Ganu, V.and M�ller-Eberhard, H. J. (1984). Molecular aspects of the complement C3 interaction with conglutinin complement receptor CR3 and complement receptor CR2. Complement 1 :165.
Tsokos, G. C., Inghirami, G., Balow, J. E. Tsoukas, C. D. Lambris, J. D. (1984). Regulation of immunoglobulin secretion by human B cells in vitro by factor H. Fed.Proc 43 :1763.
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P. (1983). Localization of Functionally Relevant Sites in Factor-H. Immunobiology 165(3-4):236.
Alsenz, J. Lambris, J. Schulz, T. F. Dierich, M. P. (1983). Localization of the C3B-Binding Site in Factor-H. Immunobiology 164(3-4):204.
Schulz, T. F., Rieber, P., Lambris, J. Riethmuller, G. Dierich, M. P. (1983). Antigenic Relationship Between the Membrane-Receptor for Factor-H, the Alpha-Chain of C-3, and A Leukocyte Surface-Antigen Defined by Monoclonal Antibody-M522. Immunobiology 164(3-4):295.
Schulz, T. F., Scharfenberger, H.Rieber, P.Lambris, J. D. Riethmuller, G. Dierich, M. P. (1983). The Leukocyte Surface Antigen-M522, Antigenically Related to the H-Receptor and the Alpha-Chain of C-3, Is Involved in the Activation of Human-Monocytes and Neutrophils. Immunobiology 165(3-4): 356.
Schulz, T. F., Scheiner, O., Alsenz, J.Lambris, J. D. Dierich, M. P. (1983). Involvement of Membrane-Associated Factor-H in the C3B-Receptor Function of Human Lymphocytes-B Investigated with Monoclonal-Antibodies Against Human Factor-H. Immunobiology 164(3-4):296.
Scheiner,O., Schulz,T., Lambris,J., Schmid,H.U., Alsenz,J. and Dierich,M.P. (1983). Role of Membrane-Associated Factor-H in the Binding of C3B-Coated Erythrocytes to Lymphoid-Cells. Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene Series A-Medical Microbiology Infectious Diseases Virology Parasitology 253(4):439.
Lambris, J. D., Cohen, P. L., Dobson, N. J. Wheeler, P. W. Papamichail, M. Ross, G. D. (1982). Effect of Antibodies to Cr-2(C3D Receptors) on Lymphocyte-Activation. Clinical Research 30(2):A514.
Lambris, J. D., Scheiner, O., Schulz, T. F. Dierich, M. P. (1982). Coupling of C3B to Erythrocytes by Disulfide Bond Formation - Preparation of Stable and Sensitive E-C3B for Hemolytic and Complement Receptor Assays. Immunobiology 162(4-5): 383.
Lambris, J. D., Schulz, T. F., Schreiner, O. Dierich, M. P. (1982). Preparation of complement C3b coated erythrocytes for hemolytic and complement receptor assays by coupling complement C3b to activated thiol erythrocytes. Immunobiology 163:203.
Macrae, E. K., Pryzwansky, K. B.Schwab, J. H. Lambris, J. D. (1982). Aggregation of Human-Leukocytes and Erythrocytes After Stimulation with Serum-Opsonized Streptococcal Cell-Wall. Journal of Cell Biology 95(2):A13.
Ross, G. D.and Lambris, J. D. (1982). Identification of 3 Forms of Ic3B That Have Distinct Structures and Receptor-Binding Site Properties. Molecular Immunology 19(11):1399.
Schreiner, O., Schulz, T., Lambris, J. Schmid, H. U. Alsenz, J.and Dierich, M. P. (1982). The Role of Membrane-Associated Factor-H for the Binding of C3B-Coated Erythrocytes to Lymphoid-Cells. Immunobiology 162(4-5):415.
Schulz, T. F., Alsenz, J., Scheiner, O. Lambris, J. D. Dierich, M. P. (1982). Use of monoclonal antibodies against factor H to investigate the role of factor H in complement C3b dependent rosette formation. Immunobiology 162:421.
Pryzwansky,K.B., Lambris,J.D., Schwab,J.H. and Macrae,E.K. (1982). Capping of Complement Receptors on Human-Neutrophils Induced by Opsonized Group A Streptococcal Cell-Walls. Journal of Cell Biology 95(2):A437.
Schulz, T. F., Scheiner, O., Alsenz, J.Lambris, J. D. Dierich, M. P. (1982). Involvement of membrane associated factor H in complement C3b dependent rosette formation demonstrated by mono clonal antibodies against human factor H. Immunobiology 163:207.
Dobson, N. J., Lambris, J. D., Bleau, S. A. Ross, G. D. (1981). Role of Human Neutrophil Complement Receptors and Beta-1H in the Release of Superoxide Anion. Federation Proceedings 40(3):1014.
Lambris, J. D., Dobson, N. J., and Ross, G. D. (1981). Isolation of Lymphocyte Membrane Complement Receptor Type-2 (the C3D Receptor) and Preparation of Receptor-Specific Antibody. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences 78(3):1828.
Newman, S. L., Dobson, N. J., Lambris, J. D., Ross, G. D. Henson, P. M. (1981). Specificity and Function of Human Macrophage Complement Receptors for Different Fragments of C-3. Federation Proceedings, 40(3):1017.
Lambris,J.D., Dobson,N.J., Dozier,M. and Ross,G.D. (1981). Antibody to the Idiotype of Anti-Beta-1H Has Specificity for Beta-1H Lymphocyte-B Membrane Beta-1H Receptors and C3B. Federation Proceedings 40 (3):1013.
Huber-Lang, M., Sarma, V., Younkin, E. M. McGuire, S. R. Lu, K. T.Neff, T.Guo, R. F.Gebhard, F. Lambris, J. D. Ward, P. A. International Immunopharmacology. Protective effects by C5aR antagonist(C5aRa) during experimental sepsis 2:1244.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V.